Hepatitis E, a Vaccine-Preventable Cause of Maternal Deaths

被引:89
作者
Labrique, Alain B. [1 ]
Sikder, Shegufta S.
Krain, Lisa J.
West, Keith P., Jr.
Christian, Parul
Rashid, Mahbubur [2 ]
Nelson, Kenrad E.
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA
[2] JiVitA Maternal & Child Hlth & Nutr Res Project, Gaibandha, Bangladesh
关键词
E VIRUS; NON-A; INFANT-MORTALITY; VITAMIN-A; EPIDEMIOLOGY; SUPPLEMENTATION; POPULATION; ANTIBODIES; INFECTION; EFFICACY;
D O I
10.3201/eid1809.120241
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis E virus (HEV) is a major cause of illness and of death in the developing world and disproportionate cause of deaths among pregnant women. Although HEV vaccine trials, including trials conducted in populations in southern Asia, have shown candidate vaccines to be effective and well-tolerated, these vaccines have not yet been produced or made available to susceptible populations. Surveillance data collected during 2001-2007 from >110,000 pregnancies in a population of approximate to 650,000 women in rural Bangladesh suggest that acute hepatitis, most of it likely hepatitis E, is responsible for approximate to 9.8% of pregnancy-associated deaths. If these numbers are representative of southern Asia, as many as 10,500 maternal deaths each year in this region alone may be attributable to hepatitis E and could be prevented by using existing vaccines.
引用
收藏
页码:1401 / 1404
页数:4
相关论文
共 35 条
[1]  
Alam Shahinul, 2009, Saudi J Gastroenterol, V15, P229, DOI 10.4103/1319-3767.56094
[2]   US military sponsored vaccine trials and La resistance in Nepal [J].
Andrews, J .
AMERICAN JOURNAL OF BIOETHICS, 2005, 5 (03) :W1-W3
[3]  
[Anonymous], 2010, Trends in Maternal Mortality: 1990 to 2008
[4]   EVIDENCE FOR A VIRUS IN NON-A, NON-B HEPATITIS TRANSMITTED VIA THE FECAL-ORAL ROUTE [J].
BALAYAN, MS ;
ANDJAPARIDZE, AG ;
SAVINSKAYA, SS ;
KETILADZE, ES ;
BRAGINSKY, DM ;
SAVINOV, AP ;
POLESCHUK, VF .
INTERVIROLOGY, 1983, 20 (01) :23-31
[5]  
Basu S, 2007, NEW ENGL J MED, V356, P2421
[6]   Hepatitis E: an emerging infection in developed countries [J].
Dalton, Harry R. ;
Bendall, Richard ;
Ijaz, Samreen ;
Banks, Malcolm .
LANCET INFECTIOUS DISEASES, 2008, 8 (11) :698-709
[7]   Serologic Assays Specific to Immunoglobulin M Antibodies against Hepatitis E Virus: Pangenotypic Evaluation of Performances [J].
Drobeniuc, Jan ;
Meng, Jihong ;
Reuter, Gabor ;
Greene-Montfort, Tracy ;
Khudyakova, Natasha ;
Dimitrova, Zoya ;
Kamili, Saleem ;
Teo, Chong-Gee .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (03) :E24-E27
[8]   Causes of neonatal and maternal deaths in Dhaka slums: Implications for service delivery [J].
Khatun, Fatema ;
Rasheed, Sabrina ;
Moran, Allisyn C. ;
Alam, Ashraful M. ;
Shomik, Mohammad Sohel ;
Sultana, Munira ;
Choudhury, Nuzhat ;
Iqbal, Mohammad ;
Bhuiya, Abbas .
BMC PUBLIC HEALTH, 2012, 12
[9]   Discovery of hepatitis E: The epidemic non-A, non-B hepatitis 30 years down the memory lane [J].
Khuroo, Mohammad Sultan .
VIRUS RESEARCH, 2011, 161 (01) :3-14
[10]   Newborn vitamin a supplementation reduced infant mortality in rural Bangladesh [J].
Klemm, Rolf D. W. ;
Labrique, Alain B. ;
Christian, Parul ;
Rashid, Mahbubur ;
Shamim, Abu Ahmed ;
Katz, Joanne ;
Sommer, Alfred ;
West, Keith P., Jr. .
PEDIATRICS, 2008, 122 (01) :E242-E250